Endothelial cell activation and/or injury in multiple sclerosis: Analysis with yon willebrand factor and thrombomodulin

Clinical Neurology

Volumn 37, Issue 4, 1997, Pages 287-291

  Kohriyama, Tatsuo ^a   Maruyama, Hirofumi ^a   Kurokawa, Katsumi ^a   Harada, Toahihide ^a   Nakamura, Shigenobu ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Blood brain barrier; Endothelial cells; Multiple sclerosis; Thrombomodulin; Von Willebrand factor

Indexed keywords

THROMBOMODULIN; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; BLOOD BRAIN BARRIER; CELL ACTIVATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MULTIPLE SCLEROSIS;

ADULT; BIOLOGICAL MARKERS; BLOOD-BRAIN BARRIER; ENDOTHELIUM, VASCULAR; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MIDDLE AGED; MULTIPLE SCLEROSIS; THROMBOMODULIN; VON WILLEBRAND FACTOR;

EID: 0030816556     PISSN: 0009918X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Gay D, Esiri M : Blood-brain barrier damage in acute multiple sclerosis plaques. An immunocytological study Brain 114 : 557-572, 1991
2. Woodroofe MN, Cuzner ML : Cytokine mRNA expression in inflammatory multiple sclerosis lesions : detection by non-radioactive in situ hybridization. Cytokine 5 : 583-588, 1993
3. Pober JS : Cytokine-mediated activation of vascular endothelium. Physiology and pathology. Am J Pathol 133 : 426-433, 1988
4. Washington R, Burton J, Todd RF, et al : Expression of immunologically relevant endothelial cell activation antigens on isolated central nervous system microvessels from patients with multiple sclerosis. Ann Neurol 35 : 89-97, 1994
5. Traugott U, Scheinberg LC, Raine CS : On the presence of Ia-positive endothelial cells and astrocytes in multiple sclerosis lesions and its relevance to antigen presentation. J Neuroimmunol 8 : 1-14, 1985
6. Kurtzke JF : Rating neurologic impairment in multiple sclerosis : an expanded disability status scale (EDSS). Neurology 33 : 1444-1452, 1983
7. Jaffe EA, Hoyer LW, Nachman RL : Synthesis of antihemophilic factor antigen by cultured human endothelial cells. J Clin Invest 52 : 2757-2764, 1973
8. Takano S, Kimura S, Ohdama S, et al : Plasma thrombomodulin in health and disease. Blood 76 : 2024-2029, 1990
9. Tsukada N, Matsuda M, Mivagi K, et al : Thrombomodulin in the sera of patients with multiple sclerosis and human lymphotropic virus type-1-associated myelopathy. J Neuroimmunol 56 : 113-116, 1995
10. Tanaka A, Ishii H, Hiraishi S, et al : Increased thrombomodulin values in plasma of diabetic men with microangiopathy. Clin Chem 37 : 269-272, 1991
11. Boehme MWJ, Nawroth PP, Kling E, et al : Serum thrombomodulin. A novel marker of disease activity in systemic lupus erythematosus. Arthritis Rheum 37 : 572-577, 1994
12. Jones DK, Perry EM, Grosso MA, et al : Release of von Willebrand factor antigen (vWF:Ag) and eicosanoids during acute injury to the isolated rat lung. Am Rev Respir Dis 145 : 1410-1415, 1992
13. Paleolog EM, Crossman DC, McVey JH, et al : Differential regulation by cytokines of constitutive and stimulated secretion of von Willebrand factor from endothelial cells. Blood 75 : 688-695, 1990
14. Ishii H, Uchiyama H, Kazama M : Soluble thrombomodulin antigen in conditioned medium is increased by damage of endothelial cells. Thromb Haemost 65 : 618-623, 1991
15. Koga S, Morris S, Ogawa H, et al : TNF modulates endothelial properties by decreasing cAMP. Am J Physiol 268 : C1104-C1113, 1995
16. Dinarello CA : Interleukin-1 and the pathogenesis of the acute-phase response. N Engl J Med 311 : 1413-1418, 1984